Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings

BACKGROUND: Recruitment is often a bottleneck in secondary prevention trials in Alzheimer disease (AD). Furthermore, screen-failure rates in these trials are typically high due to relatively low prevalence of AD pathology in individuals without dementia, especially among cognitively unimpaired. Pres...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermunt, Lisa, Muniz-Terrera, Graciela, ter Meulen, Lea, Veal, Colin, Blennow, Kaj, Campbell, Archie, Carrié, Isabelle, Delrieu, Julien, Fauria, Karine, Huesa Rodríguez, Gema, Ingala, Silvia, Jenkins, Natalie, Molinuevo, José Luis, Ousset, Pierre-Jean, Porteous, David, Prins, Niels D., Solomon, Alina, Tom, Brian D., Zetterberg, Henrik, Zwan, Marissa, Ritchie, Craig W., Scheltens, Philip, Luscan, Gerald, Brookes, Anthony J., Visser, Pieter Jelle
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945608/
https://www.ncbi.nlm.nih.gov/pubmed/31907067
http://dx.doi.org/10.1186/s13195-019-0576-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945608/
https://www.ncbi.nlm.nih.gov/pubmed/31907067
http://dx.doi.org/10.1186/s13195-019-0576-y

Ejemplares similares